NewsRadio WFLA (WFLA-AM)
NewsRadio WFLA (WFLA-AM)
BRADFORD GEYER – ATTORNEY IN THE CLASS ACTION REMDESIVIR LAWSUIT– 10 21 23
BRADFORD GEYER – ATTORNEY IN THE CLASS ACTION REMDESIVIR LAWSUIT– 10 21 23
BRADFORD GEYER – ATTORNEY IN THE CLASS ACTION REMDESIVIR LAWSUIT– 10 21 23
Saturday 21st October 2023
Attorney Bradford Geyer discusses the class-action lawsuit against remdesivir's manufacturer and its impact on patients in this episode of American Medicine Today.
Explicit
10 minutes
Informative
Eye-opening
Empowering
Thought-provoking
Supportive
About this podcast
Author:
NewsRadio WFLA (WFLA-AM)
Overview:
Categories:
Innovative Treatments & Recovery Paths
Holistic Health Innovations
Innovative Healing Arts
Sexual Stigmas & Myths
Mindful Recovery
Links:
Visit site
Episodes:
1002 (View all)
Do you want to link to this podcast?
Get the buttons here!Bradford Geyer Exposes the Remdesivir Controversy: A Deep Dive on American Medicine Today
Episode Overview
- Bradford Geyer discusses the class-action lawsuit against the manufacturer of remdesivir, revealing its alleged deceptive promotion and dangerous side effects.
- Heart-wrenching personal stories of plaintiffs underscore the devastating impact of the drug, raising crucial questions about accountability and transparency in healthcare.
- Insights from the episode shed light on the need for stringent measures to ensure the safety and well-being of patients in the healthcare system.
- Tune in to gain a deeper understanding of the critical issues surrounding the use of remdesivir in the treatment of COVID-19 and the quest for justice for the affected individuals.
- Join the conversation on American Medicine Today to stay informed and empowered about healthcare-related controversies and innovations.
It killed so many of the study participants that a compassionate oversight board had to come in and tell them to stop using it.
Ever wondered what really goes on behind the scenes with some of the drugs used to treat COVID-19? In this episode of 'American Medicine Today', attorney Bradford Geyer takes us on a journey through the murky waters of the class-action lawsuit against the makers of remdesivir. The lawsuit alleges that the drug was promoted deceptively, without fully disclosing potential side effects.
Geyer, representing the plaintiffs through the Former Feds Group, shares heart-wrenching stories of those affected, painting a vivid picture of the drug's impact on their lives. This episode doesn't just skim the surface; it dives into the critical need for transparency and accountability in healthcare. With a mix of legal insight and personal anecdotes, you'll find yourself questioning how much you really know about the medications prescribed during the pandemic.
Perfect for anyone interested in medical ethics, legal battles in healthcare, or simply wanting to stay informed, this episode promises to be both eye-opening and thought-provoking.